The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them
Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months
Gay men and transgender women who have sex with men in Nairobi and Johannesburg are active social media users, possibly providing an untapped opportunity for sexual health promotion on these platforms.
User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.
Rates of viral suppression among men significantly increase – and approach that of women – when services are provided in the community instead of in-clinic.
South African study finds people living with both HIV and mental illness are far more likely to die than their peers, regardless of HIV care.
Study among fisherfolk, sex workers, truck drivers and others at higher risk of HIV finds many are willing to try PrEP – but only for around six weeks.
An HIV testing initiative that targeted male-dominated workplaces and social spaces, and notified the sexual partners of anyone testing positive, results in 25% of men being diagnosed with HIV
New Kenyan trial providing HIV self-tests to sex workers sees high levels of partner testing – and increased condom use when men refused to test
Rates of CD4 testing in Africa have halved – yet viral load testing is only reaching around a third of people on HIV treatment